Goritsas et al. Journal of Medical Case Reports 2010, 4:9 http://www.jmedicalcasereports.com/content/4/1/9 5. Matsumoto T, Yoshimine T, Simouchi F, Shiotu H, Kuwabara N, Fukuda Y, Hoshi T: The liver in systemic lupus erythematosus. Hum Pathol 1992, 23:1151-1158. 6. Empen K, Jung MC, Engelhardt D, Sackmann M: Successful treatment of acute liver failure due to polyarteritis nodosa. Am J Med 2002, 113:849- 851. 7. Goritsas CP, Repantis M, Papadaki E, Lazarou N, Andonopoulos AN: Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hep 1997, 26:727-730. 8. Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H: The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000, 20(5):366-373. 9. Watts RA, Scott DG: Epidemiology of the vasculitides. Semin Respr Crit Care Med 2004, 25(5):455-464. 10. Shah IA, Holstege A, Riede UN: Bioptic diagnosis of Wegener’s granulomatosis in the absence of vasculitis and granulomas. Path Res Pract 1984, 178:407-412. 11. Boissy C, Bernard E, Chazal M, Furibet JG, Michiels JF, Saint-Paul MC: Wegener’s granulomatosis disclosed by hepatosplenic involvement. Gastroenetrol Clin Biol 1997, 21:633-635. 12. Zen Y, Sunagozaka H, Tsuneyama K, Masutomi K, Terasaki S, Kaneko S, Kobayashi K, Nakanuma Y: Incomplete septal cirrhosis associated with Wegener’s granulomatosis. Liver 2002, 22:388-393. 13. Snyder LS, Heigh RI, Anderson ML: Cyclophosphamide-induced hepatotoxicity in a patient with Wegener’s granulomatosis. Mayo Clin Proc 1994, 69(9):912-913. 14. Patel A, Patel A, Patel S, Jalandhara P, Thakor P: Cyclophosphamide therapy in granulomatous hepatitis: cure or culprit?. Am J Ther 2009, 16(4):367-370. 15. Ng IOL, Sturgess RP, Williams R, Portmann B: Ground-glass hepatocytes with Lafora body-like inclusions: histochemical, immunohistochemical and electron microscopic characterization. Histopathol 1990, 17:109-115. 16. Brunt EM, Bisceglie AM: Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis. Hum Pathol 2004, 35:509-512. 17. Lefkowitch JH, Lobritto SJ, Brown RS, Emond JC, Schilsky ML, Rosenthal LA, George DM, Cairo MS: Ground-glass, polyglucose-like hepatocellular inclusions: a “new” diagnostic entity. Gastroenterol 2006, 131(3):713-718. doi:10.1186/1752-1947-4-9 Cite this article as: Goritsas et al.: Hepatic involvement in Wegener’s granulomatosis: a case report. Journal of Medical Case Reports 2010 4:9. Page 5 of 5 Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral